Sunrise Primary Care Inc Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 811 N Summit St, Crescent City, FL 32112 Phone: 386-698-2279 Fax: 386-698-2239 |
T R Suggs Md Medical Clinic Pa General Practice Medicare: Not Enrolled in Medicare Practice Location: 300 S Main St, Crescent City, FL 32112 Phone: 386-698-1221 Fax: 386-698-1514 |
Aza Health Clinic/Center - Community Health Medicare: Medicare Enrolled Practice Location: 306 Union Ave, Crescent City, FL 32112 Phone: 386-698-1232 Fax: 386-698-4154 |
Sunrise Primary Care Inc Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 811 N Summit St, Crescent City, FL 32112 Phone: 386-698-2279 Fax: 386-698-2239 |
Community Rural Health Inc Internal Medicine Medicare: Medicare Enrolled Practice Location: 899 N Summit St, Crescent City, FL 32112 Phone: 386-698-1088 Fax: 386-698-1099 |
Sunrise Primary Care Inc Clinic/Center Medicare: Not Enrolled in Medicare Practice Location: 811 North Summit St, Crescent City, FL 32112 Phone: 386-698-2279 Fax: 386-698-2239 |
John F Hull Do Pa Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 921 N Summit St, Crescent City, FL 32112 Phone: 386-698-2101 Fax: 386-698-2364 |
Express Family Care Family Medicine Medicare: Medicare Enrolled Practice Location: 300 S Main St, Crescent City, FL 32112 Phone: 386-698-1221 Fax: 386-698-1514 |
Sunrise Primary Care Inc Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 811 N Summit St, Crescent City, FL 32112 Phone: 386-698-2279 Fax: 386-698-2239 |
News Archive
Peter Lee, who has steered California's Affordable Care Act marketplace since late 2011 and helped mold it into a model of what the federal health care law could achieve, announced Thursday he will leave his post in March.
The Associated Press: Officials from the Centers for Disease Control and Prevention "estimate that 1 in 22 black Americans will be diagnosed with the AIDS virus in their lifetime — more than twice the risk for Hispanics and eight times that of whites. ... the lifetime risk is 1 in 52 for Hispanics, and 1 in 170 for whites. Asian-Americans had the lowest lifetime risk, at about 1 in 222" (10/14).
Monash University researchers have revealed the role played by an enzyme that is pivotal to the process of clearing infection in the body.
Roche announced today that the U.S. Food and Drug Administration (FDA) has approved Xeloda (capecitabine) - an innovative oral chemotherapy - for the adjuvant (post-surgery) treatment of patients with Dukes' C colon cancer.
Achillion Pharmaceuticals, Inc., a leader in the discovery and development of small molecule drugs to combat the most challenging infectious diseases, today reported financial results for the three and twelve months ended December 31, 2010.
› Verified 1 days ago